189295
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation by AIM ImmunoTech outlines forward-looking statements regarding Ampligen® and its potential in treating various diseases as of Q1 2023.
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation by AIM ImmunoTech outlines forward-looking statements regarding Ampligen® and its potential in treating various diseases as of Q1 2023.
presentation
investor_presentation
33 Pages
Mondi
Virpax Pharmaceuticals 2023 Investor Presentation
investor_presentationinvestor_presentation
24 Pages
Virpax Pharmaceuticals, Inc.
Weatherford International Investor Presentation — October 2020
investor_presentationinvestor_presentation
20 Pages
Weatherford International plc
